IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q4 2025 Holdings

Filed 2026-02-17 | 24 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Brookfield Corp(BN)CL A LTD VT SH11271J107$160.4M3,496,24512.5%
Edgewise Therapeutics Inc(EWTX)COM28036F105$132.8M5,350,00010.3%
Asml Holding N V(ASML)N Y REGISTRY SHSN07059210$121.9M113,9469.5%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$99.8M1,264,0287.8%
Salesforce Inc(CRM)COM79466L302$87.5M330,1876.8%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$75.6M1,625,0005.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$74.1M2,380,0005.8%
Maplight Therapeutics Inc(MPLT)COM56565P103$64.8M3,686,6225.0%
Zenas Biopharma Inc(ZBIO)COM98937L105$52.6M1,450,0004.1%
Pharvaris N V(PHVS)COMN69605108$48.6M1,750,0003.8%
Apogee Therapeutics Inc(APGE)COM03770N101$43.0M570,0003.3%
Vaxcyte Inc(PCVX)COM92243G108$42.3M916,1603.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$39.2M660,0003.0%
Arrivent Biopharma Inc(AVBP)COM04272N102$39.1M1,942,1423.0%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$37.7M257,3272.9%
Insmed Inc(INSM)COM PAR $.01457669307$34.8M200,0002.7%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$32.6M1,200,0002.5%
4D Molecular Therapeutics in(FDMT)COM35104E100$27.4M3,650,7372.1%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$24.6M1,961,3171.9%
Enliven Therapeutics Inc(ELVN)COM29337E102$22.8M1,480,0001.8%
Valneva SE(VALN)SPONSORED ADS92025Y103$20.3M2,305,0001.6%
Lanzatech Global Inc(LNZA)COM NEW51655R200$2.2M158,1480.2%
Marqeta Inc(MQ)CLASS A COM57142B104$2.1M441,5580.2%
IO Biotech Inc(IOBT)COM449778109$1.5M2,512,4530.1%